Provided by Tiger Fintech (Singapore) Pte. Ltd.

Alnylam Pharmaceuticals

251.15
-7.2000-2.79%
Post-market: 251.150.00000.00%17:28 EDT
Volume:656.36K
Turnover:166.30M
Market Cap:32.75B
PE:-119.69
High:260.00
Open:259.92
Low:250.35
Close:258.35
Loading ...

Bet on These 4 Top-Performing Liquid Stocks for Solid Gains

Zacks
·
03 Feb

Alnylam added to US Conviction List at Goldman Sachs

TIPRANKS
·
03 Feb

CMRX Stock Skyrockets in 3 Months: Here's What You Should Know

Zacks
·
31 Jan

FDA Expands Label of AZN's Enhertu for New Breast Cancer Indication

Zacks
·
29 Jan

Top Analyst Reports for ServiceNow, Alibaba & Union Pacific

Zacks
·
28 Jan

NVO Stock Rises as New Obesity Drug Shows Superior Weight Loss

Zacks
·
27 Jan

New Strong Buy Stocks for January 27th

Zacks
·
27 Jan

Anavex Life Sciences Stock Skyrockets 95% in 3 Months: Here's Why

Zacks
·
24 Jan

Exploring Three High Growth Tech Stocks In The United States

Simply Wall St.
·
24 Jan

GILD vs. ALNY: Which Stock Is the Better Value Option?

Zacks
·
24 Jan

Here's Why Alnylam Pharmaceuticals (ALNY) is a Strong Momentum Stock

Zacks
·
23 Jan

Alnylam Pharmaceuticals Price Target Maintained With a $300.00/Share by RBC Capital

Dow Jones
·
22 Jan

TD Cowen Reaffirms Their Buy Rating on Alnylam Pharma (ALNY)

TIPRANKS
·
21 Jan

Are Medical Stocks Lagging Alnylam Pharmaceuticals (ALNY) This Year?

Zacks
·
21 Jan

New Strong Buy Stocks for January 21st

Zacks
·
21 Jan

Alnylam Pharma (ALNY) Gets a Buy from Bernstein

TIPRANKS
·
14 Jan

Alnylam positive reaction to guidance ‘makes sense,’ says JPMorgan

TIPRANKS
·
14 Jan

Alnylam Shares Rise 8% On Preliminary Product Revenue Growth

Dow Jones
·
14 Jan

ALNY Announces Preliminary 2024 Results, 2025 View & Pipeline Goals

Zacks
·
14 Jan

Piper Sandler Reaffirms Their Buy Rating on Alnylam Pharma (ALNY)

TIPRANKS
·
13 Jan